Skip to Content

CardioGenics Holdings Inc - Stock Quote CGNH

Rating as of

Morningstar's CardioGenics Holdings Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

CardioGenics Holdings Inc's Company Profile

Business Description

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company’s objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

6295 Northam Drive, Unit 8
Mississauga, ON, L4V 1W8, Canada
T +1 905 673-8501
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Jan 31, 2016
Fiscal Year End Oct 31, 2016
Stock Type Slow Growth
Employees 4